Nebraska Educational Biomedical Research Association

Nebraska Educational Biomedical Research Association, doing business as Nebraska Educational Biomedical Research, is a tax-exempt nonprofit based in Omaha, Nebraska that receives federal research funding exclusively as a sub-recipient on biomedical grants from the National Institute on Aging, a component of the National Institutes of Health under the Department of Health and Human Services.

The organization operates entirely in a sub-recipient role (100% of its awards); it holds no prime grants or federal contracts. Over the past four years, the organization has received four sub-award grants from the Board of Regents of the University of Nebraska, each targeting the same research focus: MitoQ treatment of claudication with investigation of myofiber and micro-vessel pathology. Awards were issued in September 2022, September 2023, July 2024, and August 2025, with a combined obligated value of $235 thousand across all four sub-awards. The organization serves a single customer agency, the National Institute on Aging, which funds all grants in the portfolio.

Activity is minimal and flat — one sub-award per year across the four-year window — reflecting the organization's narrow focus on a single research topic within a single university-based grant program. The recurring annual award pattern suggests continuation of the same multi-year research initiative rather than diversification or expansion into new research areas or funding streams. Nebraska Educational Biomedical Research functions as a research performer under the Board of Regents of the University of Nebraska, contributing scientific and technical capacity to federally funded biomedical research on vascular claudication and mitochondrial function rather than managing grants or contracting relationships independently.